about
sameAs
The thyroid imaging reporting and data system on US, but not the BRAFV600E mutation in fine-needle aspirates, is associated with lateral lymph node metastasis in PTC.Diabetic mastopathy: imaging features and the role of image-guided biopsy in its diagnosis.Prognostic Impact of Ultrasonography Features and (18)F-Fluorodeoxyglucose Uptake in Patients With Papillary Thyroid Microcarcinoma.Imaging-cytology correlation of thyroid nodules with initially benign cytologyDiagnostic role of conventional ultrasonography and shearwave elastography in asymptomatic patients with diffuse thyroid disease: initial experience with 57 patientsImaging findings for malignancy-mimicking nodular fasciitis of the breast and a review of previous imaging studiesImage reporting and characterization system for ultrasound features of thyroid nodules: multicentric Korean retrospective studyMalignancy risk stratification in thyroid nodules with benign results on cytology: combination of thyroid imaging reporting and data system and Bethesda system.Malignancy risk stratification in thyroid nodules with nondiagnostic results at cytologic examination: combination of thyroid imaging reporting and data system and the Bethesda System.Thyroid Nodules: Nondiagnostic Cytologic Results according to Thyroid Imaging Reporting and Data System before and after Application of the Bethesda System.Adding Ultrasound to the Evaluation of Patients with Pathologic Nipple Discharge to Diagnose Additional Breast Cancers: Preliminary Data.Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients.Malignancy Risk Stratification of Thyroid Nodules: Comparison between the Thyroid Imaging Reporting and Data System and the 2014 American Thyroid Association Management Guidelines.Thyroid Imaging Reporting and Data System and Ultrasound Elastography: Diagnostic Accuracy as a Tool in Recommending Repeat Fine-Needle Aspiration for Solid Thyroid Nodules with Non-Diagnostic Fine-Needle Aspiration Cytology.Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS).Ultrasound texture analysis: Association with lymph node metastasis of papillary thyroid microcarcinomaMammographic density estimation with automated volumetric breast density measurement.Sonographic features and ultrasonography-guided fine-needle aspiration of metastases to the thyroid glandMetastatic renal cell carcinoma in the thyroid gland: ultrasonographic features and the diagnostic role of core needle biopsyPositive predictive value of additional synchronous breast lesions in whole-breast ultrasonography at the diagnosis of breast cancer: clinical and imaging factors.Benign core biopsy of probably benign breast lesions 2 cm or larger: correlation with excisional biopsy and long-term follow-up.Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk.Photoacoustic imaging of breast microcalcifications: a preliminary study with 8-gauge core-biopsied breast specimensBetter understanding in the differentiation of thyroid follicular adenoma, follicular carcinoma, and follicular variant of papillary carcinoma: a retrospective study.Absence of Residual Microcalcifications in Atypical Ductal Hyperplasia Diagnosed via Stereotactic Vacuum-Assisted Breast Biopsy: Is Surgical Excision Obviated?HER2 expression in fine needle aspirates of lymph nodes detected by preoperative axillary ultrasound in breast cancer patients.HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors.Percutaneous ultrasound-guided vacuum-assisted removal versus surgery for breast lesions showing imaging-histology discordance after ultrasound-guided core-needle biopsy.Fine-needle aspirates CYFRA 21-1 is a useful tumor marker for detecting axillary lymph node metastasis in breast cancer patients.Is follow-up BRAF(V600E) mutation analysis helpful in the differential diagnosis of thyroid nodules with negative results on initial analysis?Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules.Heterogeneous echogenicity of the underlying thyroid parenchyma: how does this affect the analysis of a thyroid nodule?Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapyImaging surveillance of patients with breast cancer after primary treatment: current recommendationsA Study on Serum Antithyroglobulin Antibodies Interference in Thyroglobulin Measurement in Fine-Needle Aspiration for Diagnosing Lymph Node Metastasis in Postoperative PatientsApplication of Thyroid Imaging Reporting and Data System in the Ultrasound Assessment of Thyroid Nodules According to Physician Experience.Characteristics of breast cancer detected by supplementary screening ultrasonography.RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAFV600E Mutation-Negative Nodules?US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers.Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer
P50
Q30364216-0F903ABA-82E9-40F4-8907-E2EEAF00CC21Q30386120-11357DEF-FB9D-4996-B10C-520A60DFB08AQ30388188-588DEA0C-8185-4D88-BB90-714B6D55C1E3Q30426712-8CFA2F64-0488-4ACB-AE8B-1F1D0FBFB401Q30445245-031EA9EA-14C6-460A-846F-589EACBE0A53Q30445668-7616B4F2-3A76-4704-B23E-410EC04CE6EFQ30459118-2C876BD6-289F-44FD-A827-AEBF711DBB42Q30761620-8030E449-A8BD-4464-8A85-6444F45E0D20Q30843412-DD5A60E0-0EBF-42B6-8E93-1F96DC71A141Q30925784-FC09FBAC-6AFB-464F-AA1E-74DEEC9C0F9CQ30946290-C1A05149-3464-445C-9D07-CD65074938BAQ30948399-CD35EFD3-4689-4D15-BC09-C41131E95D14Q30992129-99801735-399E-4C7C-8164-C705B0E4BB61Q31028947-0DE758C1-B194-41A5-9A7C-EAA8E38C10C2Q31030409-A7C0F309-986C-41D6-B88E-AB74FC329354Q33574630-0406E1CC-3FC7-490C-B703-2ACA931C7050Q33574630-1322E5C9-941E-444E-B543-F3C57D1C0012Q33620179-09BF2CB7-EED5-4D70-8802-3177A3C623CAQ33760500-032BC571-6C4A-48C0-A4D1-F5724DE7E53EQ33864480-68788D24-373C-47FE-8EB2-F39CF987AC97Q33926061-BF5C9DDB-8739-490C-A23D-7A39ECF1B045Q33926086-6756343A-AE20-40D3-9A1F-ED110466070AQ33965769-4BE39D5B-5042-43CA-BFA5-0F12A2E89560Q34084069-89106EB7-E048-4BF8-A695-171EC3C6A67CQ34306743-66E7B54F-F8E9-42C6-99B8-A84F9B42A8ABQ34340627-BCB1D73D-7422-4513-826F-793690713B4BQ34506643-7EBB39EB-7E8E-46BF-BCD0-7356C3072F2BQ34525558-74D1317E-D212-4223-8990-2F94830E249FQ34592188-EAE2A546-C200-4FA8-8FF0-4832BFB3A97DQ34603299-5EBB7D62-55E2-4DA4-AB3D-3F66997816DEQ34625948-AA4964CB-7898-42E0-8C99-38ADAB665EF7Q34745938-947CE8A9-6931-466C-ACBD-AE86928C0090Q35044420-7B64EF4D-39FA-4201-806F-4008D5973F2BQ35075617-CD50800C-38F6-4030-AA51-5BD54126B133Q35140150-B4551DCB-E6D6-4262-A65D-2C6F99588C88Q35677418-D1C16E4B-9A01-4E70-871E-94543F1491D1Q35747732-19EC8BC3-D207-4E5C-A6DC-1DC5F70E8D20Q35793079-2753B54F-A349-4E3B-A551-B6583E09E793Q35858147-794F978F-E152-4A3C-BC36-C5F10F5DC2B2Q35911336-5A3434F4-DAE4-4974-9EAA-860CD5DF2816
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-5643-5885
@en
name
Hee Jung Moon
@ast
Hee Jung Moon
@en
Hee Jung Moon
@es
Hee Jung Moon
@nl
type
label
Hee Jung Moon
@ast
Hee Jung Moon
@en
Hee Jung Moon
@es
Hee Jung Moon
@nl
prefLabel
Hee Jung Moon
@ast
Hee Jung Moon
@en
Hee Jung Moon
@es
Hee Jung Moon
@nl
P106
P31
P496
0000-0002-5643-5885